Breeder Health Evidence Before a Puppy Deposit

Before paying a deposit, ask for the dam's and sire's MDR1 genotype test results, current eye and hip screening certificates, and a written pedigree. A breed standard describes what a Golden Retriever should look like and move like; a health screening result is a laboratory or veterinary finding about one individual dog. If the breed carries the MDR1 mutation, responsible acquisition means the breeder tests both parents, tells you each puppy's genotype in writing, and explains what that genotype means for drug choices later.

What documents should a buyer see before paying a deposit?

Ask for the paperwork before money changes hands, not after. The deposit is your leverage; once it is paid, you are negotiating from behind.

The core set is small and specific:

• MDR1 (ABCB1) genotype results for both dam and sire, issued by a laboratory, with the dog's registered name or microchip number on the report. The result will read clear/normal, carrier, or affected.
• Hip and elbow screening results, usually expressed as a score or a grade from a recognised scheme, with the dog's identity on the certificate.
• Current eye examination certificates, dated within the period the examining scheme requires.
• A pedigree showing at least three generations, so you can see whether the same dogs appear repeatedly.
• A written health statement from the breeder covering what has been tested, what has not, and why.

Two details matter more than the pile of paper. First, identity: a certificate that does not name the dog, or names a dog you cannot match to the parents, proves nothing. Second, dates: an eye certificate from four years ago is a historical document, not a current screening.

If a breeder cannot produce MDR1 results for both parents, that is not automatically a reason to walk away, but it is a reason to ask what they know and how they know it. A breeder who has never heard of the mutation is a different proposition from one who has tested some dogs and can explain the gaps.

For owners who want a structured way to think about daily care, breed benchmarks and acquisition decisions together, the Golden Retriever Atlas Australia frames these as practical, checkable reference points rather than breed mythology. That framing is useful here: a health document is a checkable fact, and a breed description is a benchmark, and the two should not be confused.

How is a breed standard different from a health screening result?

A breed standard is a written description of the ideal dog of that breed: size, proportions, head, coat, movement, temperament tendencies. It is maintained by a kennel club or breed council and it is a consensus document, not a measurement of your puppy.

A health screening result is the opposite kind of document. It is an individual measurement, taken on a named dog, on a specific date, by a specific examiner or laboratory, using a defined protocol. It says something narrow and verifiable: this dog's hips scored this, this dog's eyes were clear on this date, this dog carries one copy of this variant.

The practical consequences of the difference:

• A standard tells you what the breed is supposed to be. It cannot tell you whether the puppy in front of you will develop a problem.
• A screening result tells you about one dog at one moment. It cannot tell you what the breed as a whole looks like.
• A breeder can meet the standard perfectly and still produce puppies with a heritable condition, because the standard does not encode health.
• A breeder can produce dogs that are healthy and screened and still not match the standard closely, which matters if you intend to show or breed.

When you read a breeder's material, separate the two registers. Sentences about type, coat and movement belong to the standard. Sentences about test results, scores and genotypes belong to screening. A breeder who blends them into one reassuring paragraph is either confused or hoping you are.

Ask directly: which of these claims is a measurement, and which is a description? A good breeder will answer without irritation.

What does responsible acquisition look like when a breed carries a drug-sensitivity mutation?

The MDR1 mutation, also called ABCB1, is common enough in some lines that it should be treated as a routine part of the conversation, not a rare emergency. It affects the blood-brain barrier pump that clears certain drugs, which is why affected dogs can react severely to doses that are ordinary for other dogs.

Responsible acquisition in this context has four parts.

First, genotype both parents. Two clear parents produce clear puppies. A carrier bred to a clear dog produces a litter in which roughly half the puppies are carriers and half are clear, and none are affected. Two carriers can produce affected puppies. Knowing the parents' status lets you predict the litter, and it lets the breeder plan matings rather than guess.

Second, genotype the puppy, or accept that you will not know until you test. A puppy test is a cheek swab or blood sample sent to a laboratory. If the breeder has not tested the litter, budget for testing it yourself as soon as you bring the dog home, before any elective medication is needed.

Third, get the result in writing and keep it. You will need it at every veterinary visit for the dog's whole life. The list of drugs to avoid or dose cautiously includes several common antiparasitics, some antiemetics and some sedatives, and the exact list is long enough that no one remembers it reliably. A copy in the dog's file is the practical safeguard.

Fourth, ask what the breeder does with the information. A breeder who tests and then breeds two carriers together has the data and ignores it. A breeder who tests, publishes the results, and explains the mating choices is using the data. The second behaviour is what you are paying for.

This is also where the acquisition conversation should widen beyond the puppy. Ask how the breeder raises the litter, what socialisation the puppies receive, and whether they will take the dog back if your circumstances change. These questions are not about health screening, but they belong in the same decision.

Questions worth asking in writing

Put your questions in an email so the answers are on record. A breeder who answers carefully in writing is showing you how they will behave if something goes wrong later.

• What are the dam's and sire's MDR1 genotypes, and can you send the laboratory reports?
• Which screening schemes were used for hips, elbows and eyes, and what were the results and dates?
• Has either parent produced a puppy with a known heritable condition?
• Will the puppies be MDR1 tested before they leave, and will I receive the result?
• What is your policy if the dog develops a condition covered by a health guarantee?
• Can I speak to owners of previous litters?

You will not always get complete answers. What you are assessing is not perfection but transparency: whether the breeder distinguishes what they know from what they assume, and whether they volunteer the limits of their own data.

Reading the evidence without being led by it

Health evidence narrows uncertainty; it does not remove it. A clear MDR1 result removes one specific risk. Good hip scores reduce the probability of one specific problem. Neither tells you whether the dog will be sound at ten, easy to live with at three, or suited to your household.

So treat the documents as a floor, not a ceiling. The floor is: both parents tested for the mutation, screening results with names and dates, a pedigree you can read, and a breeder who answers questions in writing. Above that floor, the decision is about the individual dog and the individual breeder, and no certificate substitutes for that judgement.

If a breeder resists showing you the paperwork before a deposit, that resistance is itself information. The documents exist or they do not. Asking to see them is a normal part of buying a dog from someone who claims to breed carefully, and it should be an easy request to grant.

Reference: AKC Golden Retriever breed page.